Asarina Pharma is developing Sepranolone, the world’s first dedicated treatment for PMDD. With a new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) we aim to develop new, safe therapies for severe menstrual-related and stress-related conditions still widely untreated.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.